Transforming Diagnostic Device Development with LyoDots

Part 1 – Transforming Diagnostic Device Development with LyoDots

LyoDots® are a unique miniaturized format of lyophilized reagent that can revolutionize diagnostic device development. In this two-part series we explore how instrument and assay designers can take advantage of this novel format. In Part 1, we highlight the characterization and functions of LyoDots, and in the Part 2, we uncover specific LyoDot benefits that can be incorporated during the diagnostic device development process.

 

Diagnostic Device Development with LyoDots

LyoDots are the results of lyophilized (freeze-dried) reagent technology designed for use in diagnostic assays and biochemical applications. They are small, uniformly shaped dots created through the lyophilization process, which involves freezing the liquid form of a reagent and then removing the water content through sublimation. The resulting LyoDots are a stable, dry product that retains the activity and functionality of the original reagent. LyoDots are based on proprietary Argonaut lyophilization technologies and are provided as a lyophilization service.

Transforming Diagnostic Device Development with LyoDots
Comparison of common lyophilized bead and dot formats.

 

LyoDots are manufactured by dispensing liquid reagents onto a pretreated surface which is then subsequently freeze-dried. This process ensures reagents remain stable and effective. Importantly, the adherent surface on LyoDots ensures the lyophilized reagents maintain positional correctness and physical stability. The process allows each LyoDot to contain formulated reagent of between 0.1 – 10 µl.

 

Importance of LyoDots Size in Diagnostics Device Development

The size of LyoDots is under 4 mm in diameter with a height/ thickness less than 500 µm (0.5 mm). The dome formation of LyoDots has a reduced height dimension compared to a spherical bead shape. This is important as many in-vitro diagnostic applications utilize cartridges with microfluidic dimensions which cannot accommodate lyophilized beads with a diameter greater than 1 mm. The standardized flat, circular dome shape fits into smaller spaces compared to traditional lyophilized beads, enabling device miniaturization. See white paper for example of the utilization of LyoDots in qPCR assay.

LyoDots are composed of 0.1-10 µl reagent with diameter <4mm and height <0.5mm

LyoDots enable significant miniaturization of diagnostic reagents as it also results in reduced liquid requirement. This reduction in both size and volume has fundamental advantages in diagnostic device development. LyoDots allow assay developers and manufacturers to reduce cartridge or instrument footprint, lower consumable costs and simplify microfluidics, allowing greater miniaturization (1, 2, 3, and 4).

 

LyoDot Feature Benefit in Diagnostic Devices
0.1ul to 10ul formulated reagent Appropriate for individual reaction
<0.5 mm height Can be used in channels, small reservoirs
<4 mm in diameter Can be used in channels, small reservoirs
Adherent film Anchored reagents, optimized rehydration

 

LyoDot Advantages Beyond Form

 

Anchored in Place

LyoDots are supported by a mechanical film, which not only provides structural integrity but also makes them easy to handle. This latter feature is important for a seamless integration into device assembly lines using standard pick-and-place automation devices. LyoDots can be anchored in place, ensuring they remain stable and rehydrate uniformly, improving test reliability. While traditional lyophilized beads and cakes can move or break apart during transport, leading to inconsistent results.

 

Stable at Room Temperature

LyoDots maintain stability at room temperature, reducing the need for cold chain shipping and storage.  Beyond the savings from removing cold chain logistics, LyoDots also have a positive environmental impact (e.g., reduced carbon footprint) compared to emissions from products that required cold-chain manipulation.

LyoDots do not require cold-chain logistics

 

Precise Placement

Robotic systems can be used for precise placement of LyoDots into diagnostic cartridges. Automated systems provide consistent positioning and reduces the risk of material loss. Proper placement and distance from welding points is necessary to prevent damage to LyoDots.

 

Efficient Rehydration

Ensuring complete and consistent rehydration is crucial for maintaining the performance of the diagnostic assay. LyoDots are designed to rehydrate efficiently, reducing the risk of incomplete reconstitution. LyoDots are stable at room temperature and during transport, preventing premature rehydration.

 

Overall Lower Cost

By reducing reagent volumes and improving efficiency, LyoDots can lower the overall cost of diagnostic tests compared to traditional lyophilization methods. This is particularly important for making diagnostic tests more affordable and accessible. Importantly, LyoDots are applicable for an individual reaction, whereas lyophilized cake or bead formats are often used to make a reservoir pool that then is fed into individual reactions.

LyoDots are applicable for individual reactions

 

Summary of Diagnostic Device Development with LyoDots

In summary, leveraging the benefits of LyoDots can transform your diagnostic device development, leading to more compact, efficient, and environmentally friendly solutions.

In Part 2 we go into further details on implementing LyoDots into instrumentation, cartridges, and diagnostic devices.

For more information on LyoDots or other lyophilized formats such as cakes and beads, Contact Us.

LyoDotsTM is trademarked by Argonaut Manufacturing Services.

 

(1) Primiceri E, Chiriacò MS, Notarangelo FM, Crocamo A, Ardissino D, Cereda M, Bramanti AP, Bianchessi MA, Giannelli G, Maruccio G. Key Enabling Technologies for Point-of-Care Diagnostics. Sensors (Basel). 2018 Oct 24;18(11):3607

(2) Wang X, Hong XZ, Li, YW et al. Microfluidics-based strategies for molecular diagnostics of infectious diseases. Military Med Res 9, 11 (2022)

(3) Xie Y, Dai L, Yang Y. Microfluidic technology and its application in the point-of-care testing field. Biosensors and Bioelectronics: X, Volume 10, 2022.

(4) Escobar, A.; Diab-Liu, A.; Bosland, K.; Xu, C.-q. Microfluidic Device-Based Virus Detection and Quantification in Future Diagnostic Research: Lessons from the COVID-19 Pandemic. Biosensors 2023, 13, 935

© Copyright Argonaut Manufacturing Services

Drug Product Fill/Finish

The world’s leading fill/finish technology is available for you in our facilities. Equipped with advanced robotics, our automated state-of-the-art line is specially designed to reduce risk and maximize fill yield.

Reagent & Kit Manufacturing

A complete cGMP supply chain service is available for your diagnostic or life science kits. From formulation to QC, and kitting to shipping, we handle your manufacturing needs. Trusted by industry leaders.

Lyophilization Services

There are significant technical and business advantages to transitioning liquid components into a lyophilized format. Our LyoDose™ beads technology is available for you. We know what works, and your project reaps the benefits.

Whitepapers

See our other thought-provoking white papers and get industry-leading insights.